Terfenadine therapy: can we justify the risks?
Rangno
R
R
D002170:Canada; D004347:Drug Interactions; D011307:Drug Prescriptions; D005060:Europe; D006321:Heart / Q000187:drug effects*; D006323:Heart Arrest / Q000139:chemically induced* / Q000209:etiology; D006634:Histamine H1 Antagonists / Q000009:adverse effects*; D006801:Humans; D004366:Nonprescription Drugs; D012307:Risk Factors; D016593:Terfenadine / Q000009:adverse effects*
D006634:Histamine H1 Antagonists; D004366:Nonprescription Drugs; D016593:Terfenadine